Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs116446171
rs116446171
0.710 GeneticVariation BEFREE Three of the five genome-wide significant SNPs from the DLBCL GWAS were significantly associated with DLBCL in our study population, including the top finding from the GWAS, EXOC2 rs116446171, which achieved genome-wide significance in our data (per allele OR = 2.04, 95% CI = 1.63-2.56; ptrend = 3.9 × 10(-10)). 25611436

2015

dbSNP: rs116446171
rs116446171
G 0.710 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs1323292
rs1323292
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs140522
rs140522
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs1444766
rs1444766
G 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs16978630
rs16978630
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs2425752
rs2425752
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs3890745
rs3890745
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs806321
rs806321
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019

dbSNP: rs7712513
rs7712513
C 0.700 GeneticVariation GWASCAT Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. 26460308

2015

dbSNP: rs7765004
rs7765004
C 0.700 GeneticVariation GWASCAT Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. 26460308

2015

dbSNP: rs13255292
rs13255292
T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs2523607
rs2523607
A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs2681416
rs2681416
A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs4733601
rs4733601
A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs79464052
rs79464052
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs79480871
rs79480871
T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 25261932

2014

dbSNP: rs751837
rs751837
0.700 GeneticVariation GWASCAT Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. 21471979

2011

dbSNP: rs111724149
rs111724149
0.700 GeneticVariation UNIPROT

dbSNP: rs35090414
rs35090414
0.700 GeneticVariation UNIPROT

dbSNP: rs387907272
rs387907272
0.100 GeneticVariation BEFREE MYD88 p.L265P and CD79B p.Y196C/H mutations were analyzed in diffuse large B-cell lymphoma (DLBCL) patients whose tumor samples were available (N = 29). 31436356

2019

dbSNP: rs387907272
rs387907272
0.100 GeneticVariation BEFREE High frequencies of the hotspot <i>MYD88</i>(L265P) mutation are observed in extranodal diffuse large B-cell lymphoma and Waldenström macroglobulinemia, thereby demonstrating this mutation's potential as a disease marker. 31699794

2019

dbSNP: rs387907272
rs387907272
0.100 GeneticVariation BEFREE MYD88 L265P is the most common mutation in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) and one of the most frequent in poor-prognosis subtypes of diffuse large B-cell lymphoma (DLBCL). 31698464

2019

dbSNP: rs387907272
rs387907272
0.100 GeneticVariation BEFREE <i>Results</i>: MYD88 L265P mutations were detected in 22 of 29 samples from 14 patients with diffuse large B-cell lymphomas and one patient with lymphoplasmacytoid lymphoma. 31603365

2019

dbSNP: rs387907272
rs387907272
0.100 GeneticVariation BEFREE ST2825 has the potential for clinical use in patients with L265P DLBCL, and other B‑cell neoplasms driven by activated MYD88 signaling. 31432184

2019